Treatment of lupus crisis with IgIV
Intravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high dosages, propitious a prolonged remission of SLE. We show the case of a male patient 16 years old, with SLE diagnosis until 1993, and LN phase IV. He attend...
Saved in:
Published in | Revista alergia Mexico (Tecamachalco, Pueblo, Mexico : 1993) Vol. 45; no. 6; pp. 143 - 146 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | Spanish |
Published |
Mexico
01.11.1998
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Intravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high dosages, propitious a prolonged remission of SLE.
We show the case of a male patient 16 years old, with SLE diagnosis until 1993, and LN phase IV. He attend to hospital with a Lupic Crisis, positives ANAs, DNAds, ScL 427, C3 45, C4 13, IgG 179, urinary sediment: leukocytes 30-40 xc, erythrocytes 8-10 xc. Renal failure: BUN 243, seric Cr: 10.16. I.v. Ig administrated 400 mgs k do. And nephrologic assistance, NK.
There was improvement after infusion, clinical and serological, persisting with renal failure. The mechanism by which i.v. Ig might have effected improvement in this patient was reviewed.
The use in our patient with SLE and LN was satisfactory. Is difficult affirm categorical the outcome or failure of i.v. Ig in patients with SLE, even report founded are only few cases report. |
---|---|
AbstractList | BACKGROUNDIntravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high dosages, propitious a prolonged remission of SLE.MATERIAL AND METHODWe show the case of a male patient 16 years old, with SLE diagnosis until 1993, and LN phase IV. He attend to hospital with a Lupic Crisis, positives ANAs, DNAds, ScL 427, C3 45, C4 13, IgG 179, urinary sediment: leukocytes 30-40 xc, erythrocytes 8-10 xc. Renal failure: BUN 243, seric Cr: 10.16. I.v. Ig administrated 400 mgs k do. And nephrologic assistance, NK.RESULTSThere was improvement after infusion, clinical and serological, persisting with renal failure. The mechanism by which i.v. Ig might have effected improvement in this patient was reviewed.CONCLUSIONThe use in our patient with SLE and LN was satisfactory. Is difficult affirm categorical the outcome or failure of i.v. Ig in patients with SLE, even report founded are only few cases report. Intravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high dosages, propitious a prolonged remission of SLE. We show the case of a male patient 16 years old, with SLE diagnosis until 1993, and LN phase IV. He attend to hospital with a Lupic Crisis, positives ANAs, DNAds, ScL 427, C3 45, C4 13, IgG 179, urinary sediment: leukocytes 30-40 xc, erythrocytes 8-10 xc. Renal failure: BUN 243, seric Cr: 10.16. I.v. Ig administrated 400 mgs k do. And nephrologic assistance, NK. There was improvement after infusion, clinical and serological, persisting with renal failure. The mechanism by which i.v. Ig might have effected improvement in this patient was reviewed. The use in our patient with SLE and LN was satisfactory. Is difficult affirm categorical the outcome or failure of i.v. Ig in patients with SLE, even report founded are only few cases report. |
Author | Olalde Carmona, R Vázquez García, M J Escárcega Barbosa, D Juárez, J A |
Author_xml | – sequence: 1 givenname: M J surname: Vázquez García fullname: Vázquez García, M J organization: Servicio de inmunología clínica y alergia, CMN 20 de Noviembre, ISSSTE, México – sequence: 2 givenname: R surname: Olalde Carmona fullname: Olalde Carmona, R – sequence: 3 givenname: J A surname: Juárez fullname: Juárez, J A – sequence: 4 givenname: D surname: Escárcega Barbosa fullname: Escárcega Barbosa, D |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/9951325$$D View this record in MEDLINE/PubMed |
BookMark | eNotj8tqwzAQRbVISZO0n1AQFLozaGSNbC9L6MMQ6MZ0a2RplLj4Vcmm9O8bqFeHC4cLZ882wzjQhu2EEDJBQLhl-xi_rgsLrbZsWxQIqcQde6wCmbmnYeaj590yLZHb0MY28p92vvDyXH7esRtvukj3Kw-sen2pju_J6eOtPD6fkglTTHyjG9C6oFy7XKBTKBvjhFcSlXdOespQKcwzsOiJBDbKkAdhHSBaC-mBPf3fTmH8XijOdd9GS11nBhqXWOsCMqFBXcWHVVyanlw9hbY34bdeo9I__JNHxA |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM 7X8 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Tratamiento de crisis lúpica con IgIV |
EndPage | 146 |
ExternalDocumentID | 9951325 |
Genre | English Abstract Journal Article Case Reports |
GroupedDBID | 77H ABDBF ADBBV ADCUG AEGXH ALMA_UNASSIGNED_HOLDINGS APOWU BAWUL BCNDV CGR CUY CVF DIK EBD ECM EIF EML EMOBN ESX F5P FRP GROUPED_DOAJ GX1 M~E NPM OK1 SV3 TUS W2D ZXP ~8M 7X8 |
ID | FETCH-LOGICAL-p535-fb6b1669e86d805d452bad0f4254fdd2fe75445871c5fee05b4aef10cd155cc13 |
ISSN | 0002-5151 |
IngestDate | Thu Apr 11 15:17:41 EDT 2024 Sat Sep 28 07:33:00 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 6 |
Language | Spanish |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p535-fb6b1669e86d805d452bad0f4254fdd2fe75445871c5fee05b4aef10cd155cc13 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Report-3 ObjectType-Case Study-4 |
PMID | 9951325 |
PQID | 69170614 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_69170614 pubmed_primary_9951325 |
PublicationCentury | 1900 |
PublicationDate | 1998 Nov-Dec 19981101 |
PublicationDateYYYYMMDD | 1998-11-01 |
PublicationDate_xml | – month: 11 year: 1998 text: 1998 Nov-Dec |
PublicationDecade | 1990 |
PublicationPlace | Mexico |
PublicationPlace_xml | – name: Mexico |
PublicationTitle | Revista alergia Mexico (Tecamachalco, Pueblo, Mexico : 1993) |
PublicationTitleAlternate | Rev Alerg Mex |
PublicationYear | 1998 |
SSID | ssj0025964 |
Score | 1.2933809 |
Snippet | Intravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high dosages,... BACKGROUNDIntravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 143 |
SubjectTerms | Acute Disease Adolescent Humans Immunoglobulins, Intravenous - therapeutic use Lupus Erythematosus, Systemic - therapy Lupus Nephritis - therapy Male |
Title | Treatment of lupus crisis with IgIV |
URI | https://www.ncbi.nlm.nih.gov/pubmed/9951325 https://search.proquest.com/docview/69170614 |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swGBVpYaMvpd1W1vVm6N6ChxVLqvVYek1G2j1kpW9B13SQJiGOoeTX95Pk2F5poduLsC1jbB370_kuOkbou4Z5QBmegJPDOzEYPBVn2kJjTpixMlXE6xb0b9j1b9K7p_etVrdRtVQs5A-1fHVdyf-gCscAV7dK9h-QrS4KB2Ab8IUWEIb2fRhXVeJA-cbFrMjbYAScxIgPr3ZH3bsm-XR5ACCDbZgT5qM_ot03T_AeOI45MEo8CvUgxsqHTn8VRoaczOocHzjgzbDsnc-x4yVMLMv2FXwvfv_ck9F-nW26HYuxNq6wBIZF_FWi2CvCJeYhit2r46oXuSq7lBkJnxSZ5qIuUNbVuj1chSlq0wvkCTdNb1CSLF-xph3FQbupgeHs0YPIgRGmYan0C53ssmcNraXY1Xaed39WnjflQUdsdQ8b6EN5-tuOhScYgy20WXoG0WmAeRu1TP4JfeyXtQ-f0XGFdjS1kUc7CmhHDu3Iof0FDS4vBmfXcfmLi3hGUxpbySRmjJuM6SyhmtCOFDqxYEiJ1bpjjdMnpODUuqJAk1BJhLE4URpooFI43UHrk-nEfEVRxpTOLLa6QwQBFihVSolKLNfsJNE83UVHqwcdggVxaSExMdMiHzLuJJQw2UU74fmHsyB0MizH6NtbHXtoo4Z6H60v5oU5AI62kId-_J8B_Wk3vw |
link.rule.ids | 315,783,787 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+of+lupus+crisis+with+IgIV&rft.jtitle=Revista+alergia+Mexico+%28Tecamachalco%2C+Pueblo%2C+Mexico+%3A+1993%29&rft.au=V%C3%A1zquez+Garc%C3%ADa%2C+M+J&rft.au=Olalde+Carmona%2C+R&rft.au=Ju%C3%A1rez%2C+J+A&rft.au=Esc%C3%A1rcega+Barbosa%2C+D&rft.date=1998-11-01&rft.issn=0002-5151&rft.volume=45&rft.issue=6&rft.spage=143&rft_id=info%3Apmid%2F9951325&rft.externalDocID=9951325 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-5151&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-5151&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-5151&client=summon |